Development of advanced analytical kits launched by EXBIO
ISLH 2024 conference is coming - we look forward to a personal meeting with you on EXBIO booth!
Good news should travel fast
4 - 8 May 2024, Edinburgh, Scotland
CD161 belongs to promising biomarkers with immunotherapeutic potential.
Evaluation of cytokine profile in cancer cells is an important diagnostic tool.
We present a set of antibodies to plasma cell markers.
We present here a brief summary on plasmacytoid dendritic cells and their main markers.
Today we focus briefly on a promising target of cancer therapy.
We present two monoclonal antibodies for detection of BrdU.
Today we introduce an important marker and prognostic factor which plays crucial role in regulation of apoptosis.